Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Health Alert: Worldwide Caution – Updated Public Health Arrival Restrictions and Enhanced Ebola Screening – May 22, 2026 - U.S. Embassy & Consulate in Thailand